BlackRock »

Rani Therapeutics Hldgs shares owned by BlackRock

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $137k 64k 2.16

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Rani Therapeutics Hldgs

Armistice Capital
Vanguard Group
Nan Fung Group Holdings
Alphabet
United Services Automobile Association
Stifel Financial
Geode Capital Management
Kestra Private Wealth Services
Northern Trust
Luther King Capital Management Corporation
Bank of America Corporation
Bridgeway Capital Management
BlackRock
Marc Lasry
Mot

View all funds holding Rani Therapeutics Hldgs